439 related articles for article (PubMed ID: 11241284)
1. Interleukin-1beta costimulates interferon-gamma production by human natural killer cells.
Cooper MA; Fehniger TA; Ponnappan A; Mehta V; Wewers MD; Caligiuri MA
Eur J Immunol; 2001 Mar; 31(3):792-801. PubMed ID: 11241284
[TBL] [Abstract][Full Text] [Related]
2. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.
Cooper MA; Fehniger TA; Turner SC; Chen KS; Ghaheri BA; Ghayur T; Carson WE; Caligiuri MA
Blood; 2001 May; 97(10):3146-51. PubMed ID: 11342442
[TBL] [Abstract][Full Text] [Related]
3. Differential IFN-γ production by adult and neonatal blood CD56+ natural killer (NK) and NK-like-T cells in response to Trypanosoma cruzi and IL-15.
Guilmot A; Carlier Y; Truyens C
Parasite Immunol; 2014 Jan; 36(1):43-52. PubMed ID: 24102464
[TBL] [Abstract][Full Text] [Related]
4. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
Fehniger TA; Shah MH; Turner MJ; VanDeusen JB; Whitman SP; Cooper MA; Suzuki K; Wechser M; Goodsaid F; Caligiuri MA
J Immunol; 1999 Apr; 162(8):4511-20. PubMed ID: 10201989
[TBL] [Abstract][Full Text] [Related]
5. Invasive Surgery Impairs the Regulatory Function of Human CD56 bright Natural Killer Cells in Response to Staphylococcus aureus. Suppression of Interferon-γ Synthesis.
Reinhardt R; Pohlmann S; Kleinertz H; Hepner-Schefczyk M; Paul A; Flohé SB
PLoS One; 2015; 10(6):e0130155. PubMed ID: 26090673
[TBL] [Abstract][Full Text] [Related]
6. Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation.
De Maria A; Bozzano F; Cantoni C; Moretta L
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):728-32. PubMed ID: 21187373
[TBL] [Abstract][Full Text] [Related]
7. Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12.
Parihar R; Trotta R; Roda JM; Ferketich AK; Tridandapani S; Caligiuri MA; Carson WE
Cancer Res; 2005 Oct; 65(19):9099-107. PubMed ID: 16204085
[TBL] [Abstract][Full Text] [Related]
8. Interferon-γ production by tubulointerstitial human CD56
Law BMP; Wilkinson R; Wang X; Kildey K; Lindner M; Rist MJ; Beagley K; Healy H; Kassianos AJ
Kidney Int; 2017 Jul; 92(1):79-88. PubMed ID: 28396119
[TBL] [Abstract][Full Text] [Related]
9. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets.
Yu J; Mao HC; Wei M; Hughes T; Zhang J; Park IK; Liu S; McClory S; Marcucci G; Trotta R; Caligiuri MA
Blood; 2010 Jan; 115(2):274-81. PubMed ID: 19897577
[TBL] [Abstract][Full Text] [Related]
10. Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals.
Korbel DS; Norman PJ; Newman KC; Horowitz A; Gendzekhadze K; Parham P; Riley EM
J Immunol; 2009 May; 182(10):6426-34. PubMed ID: 19414796
[TBL] [Abstract][Full Text] [Related]
11. TL1A synergizes with IL-12 and IL-18 to enhance IFN-gamma production in human T cells and NK cells.
Papadakis KA; Prehn JL; Landers C; Han Q; Luo X; Cha SC; Wei P; Targan SR
J Immunol; 2004 Jun; 172(11):7002-7. PubMed ID: 15153521
[TBL] [Abstract][Full Text] [Related]
12. Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gamma.
Kondadasula SV; Roda JM; Parihar R; Yu J; Lehman A; Caligiuri MA; Tridandapani S; Burry RW; Carson WE
Blood; 2008 Apr; 111(8):4173-83. PubMed ID: 18174382
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56
Veneziani I; Alicata C; Pelosi A; Landolina N; Ricci B; D'Oria V; Fagotti A; Scambia G; Moretta L; Maggi E
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35091452
[TBL] [Abstract][Full Text] [Related]
14. Participation of the CD94 receptor complex in costimulation of human natural killer cells.
Voss SD; Daley J; Ritz J; Robertson MJ
J Immunol; 1998 Feb; 160(4):1618-26. PubMed ID: 9469418
[TBL] [Abstract][Full Text] [Related]
15. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15.
Dunne J; Lynch S; O'Farrelly C; Todryk S; Hegarty JE; Feighery C; Doherty DG
J Immunol; 2001 Sep; 167(6):3129-38. PubMed ID: 11544298
[TBL] [Abstract][Full Text] [Related]
16. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity.
Fehniger TA; Cooper MA; Nuovo GJ; Cella M; Facchetti F; Colonna M; Caligiuri MA
Blood; 2003 Apr; 101(8):3052-7. PubMed ID: 12480696
[TBL] [Abstract][Full Text] [Related]
17. Salmonella induced IL-23 and IL-1beta allow for IL-12 production by monocytes and Mphi1 through induction of IFN-gamma in CD56 NK/NK-like T cells.
van de Wetering D; de Paus RA; van Dissel JT; van de Vosse E
PLoS One; 2009 Dec; 4(12):e8396. PubMed ID: 20027291
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells.
Keating SE; Zaiatz-Bittencourt V; Loftus RM; Keane C; Brennan K; Finlay DK; Gardiner CM
J Immunol; 2016 Mar; 196(6):2552-60. PubMed ID: 26873994
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer.
Hunter CA; Timans J; Pisacane P; Menon S; Cai G; Walker W; Aste-Amezaga M; Chizzonite R; Bazan JF; Kastelein RA
Eur J Immunol; 1997 Nov; 27(11):2787-92. PubMed ID: 9394800
[TBL] [Abstract][Full Text] [Related]
20. The natural product phyllanthusmin C enhances IFN-γ production by human NK cells through upregulation of TLR-mediated NF-κB signaling.
Deng Y; Chu J; Ren Y; Fan Z; Ji X; Mundy-Bosse B; Yuan S; Hughes T; Zhang J; Cheema B; Camardo AT; Xia Y; Wu LC; Wang LS; He X; Kinghorn AD; Li X; Caligiuri MA; Yu J
J Immunol; 2014 Sep; 193(6):2994-3002. PubMed ID: 25122922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
